FSTX · Categories · Form 4

FSTX - SEC Form 4 insider transactions

F-star Therapeutics Inc. (FSTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FSTX

• 1182d
  SEC Form 4: Kayitalire Louis returned $178,135 worth of shares to the company (25,019 units at $7.12), closing all direct ownership in the company to satisfy tax liability

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Forster Eliot returned $526,588 worth of shares to the company (73,959 units at $7.12), closing all direct ownership in the company (for withholding tax)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4 filed by Klein Pamela M.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Deptula-Hicks Darlene M returned $181,838 worth of shares to the company (25,539 units at $7.12), closing all direct ownership in the company to cover withholding tax

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Brady Todd C closing all direct ownership in the company (withholding tax)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Brewis Neil returned $66,750 worth of shares to the company (9,375 units at $7.12), closing all direct ownership in the company (for withholding tax)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Race Geoffrey closing all direct ownership in the company to cover taxes

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Benz Edward Jr returned $31,221 worth of shares to the company (4,385 units at $7.12), closing all direct ownership in the company (tax withholding)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Bermingham Nessan returned $45,055 worth of shares to the company (6,328 units at $7.12), closing all direct ownership in the company (for tax liability)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1182d
  SEC Form 4: Arkowitz David closing all direct ownership in the company (for withholding tax)

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1241d
  SEC Form 4: Race Geoffrey exercised 3,937 shares at a strike of $0.11

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1400d
  SEC Form 4: Forster Eliot exercised 260,977 shares at a strike of $0.11, increasing direct ownership by 163% to 421,537 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1400d
  SEC Form 4: Brewis Neil exercised 76,619 shares at a strike of $0.11, increasing direct ownership by 202% to 114,463 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Brady Todd C

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Race Geoffrey

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Benz Edward Jr

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Klein Pamela M.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Bermingham Nessan

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1442d
  SEC Form 4 filed by Arkowitz David

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1521d
  SEC Form 4 filed by Forster Eliot

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1521d
  SEC Form 4 filed by Deptula-Hicks Darlene M

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1521d
  SEC Form 4 filed by Kayitalire Louis

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1521d
  SEC Form 4 filed by Brewis Neil

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1604d
  SEC Form 4 filed by Kayitalire Louis

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1604d
  SEC Form 4 filed by Deptula-Hicks Darlene M

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1604d
  SEC Form 4 filed by Brewis Neil

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1604d
  SEC Form 4 filed by Forster Eliot

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1671d
  SEC Form 4: Kayitalire Louis sold $437 worth of shares (64 units at $6.83) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 54,255 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1701d
  SEC Form 4: Kayitalire Louis sold $462 worth of shares (64 units at $7.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 54,319 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1744d
  SEC Form 4: Bermingham Nessan was granted 16,875 units of Common Stock (Amendment)

  4/A - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1744d
  SEC Form 4: DEPTULA-HICKS DARLENE M was granted 26,437 units of Common Stock (Amendment)

  4/A - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1744d
  SEC Form 4: Kayitalire Louis was granted 26,437 units of Common Stock (Amendment)

  4/A - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1791d
  SEC Form 4: Kayitalire Louis sold $8,885 worth of Common Stock (1,054 units at $8.43), decreasing direct ownership by 2% to 54,383 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by Krol Patrick Johan Hendrik

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by F-star Therapeutics, Inc.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by Brady Todd C

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by F-star Therapeutics, Inc.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by Race Geoffrey

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by F-star Therapeutics, Inc.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1822d
  SEC Form 4 filed by F-star Therapeutics, Inc.

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1910d
  SEC Form 4 filed by Eliot Forster

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1910d
  SEC Form 4 filed by Neil Brewis

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1910d
  SEC Form 4 filed by M Darlene Deptula-Hicks

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1910d
  SEC Form 4 filed by Louis Kayitalire

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: Neil Brewis was granted 18,000 units of Common Stock, increasing ownership by 91% to 37,844 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: Eliot Forster was granted 142,000 units of Common Stock, increasing ownership by 765% to 160,560 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: Louis Kayitalire was granted 29,000 units of Common Stock, increasing ownership by 110% to 55,437 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: Nessan Bermingham was granted 87,000 units of Common Stock, increasing ownership by 516% to 103,875 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: Jr Edward Benz was granted 4,385 units of Common Stock

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
• 1947d
  SEC Form 4: M Darlene Deptula-Hicks was granted 30,000 units of Common Stock, increasing ownership by 113% to 56,437 units

  4 - F-star Therapeutics, Inc. (0001566373) (Issuer)

Other FSTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends